ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0940

Effect of an 8-week Tailored Physical Therapy Program on Sexual Function in Women with Systemic Sclerosis and Idiopathic Inflammatory Myopathies: A Pilot Controlled Study

Barbora Hermankova1, Maja Spiritovic1, Sabina Oreska2, Hana Storkanova2, Karel Pavelka3, Ladislav Šenolt4, Jiří Vencovský4, Radim Becvar2 and Michal Tomcik2, 1Institute of Rheumatology, Department of Physiotherapy, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, Prague, Czech Republic, 2Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 3Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Praha, Czech Republic, 4Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic

Meeting: ACR Convergence 2022

Keywords: Myopathies, Outcome measures, physical therapy, Scleroderma, Sexual Function

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Systemic rheumatic diseases like systemic sclerosis (SSc) and idiopathic inflammatory myopathies (IIM) may affect all aspects of life, including sexual health. However, no non-pharmacological treatment has been proposed to date. This is the pilot project aiming to investigate the effect of an 8-week physical therapy program on sexual function in women with SSc and IIM.

Methods: In total, 12 women with SSc and 4 women with IIM, who fulfilled the ACR/EULAR 2013 criteria for SSc and the Bohan/Peter 1975 criteria for DM/PM, were enrolled in the study. Based on patient’s possibilities and willingness to participate in the program, they were divided into an intervention group (IG) (6 SSc/2 IIM, mean age: 46.8±3.1 years) and a control group (CG) (6 SSc/2 IIM, mean age: 46.3±3.0 years). The IG underwent the 8-week tailored physiotherapy program, including the pelvic floor exercise and physiotherapy of musculoskeletal problems subjectively limiting the patient’s sexual function (1 hour supervised physiotherapy twice weekly), whereas the control group received no specialized therapy. At weeks 0 and 8, all patients filled in questionnaires assessing sexual function: Female Sexual Function Index (FSFI), Brief Index of Sexual Functioning for Women (BISF-W); sexual quality of life: Sexual Quality of Life-Female (SQoL-F); functional ability: Health Assessment Questionnaire (HAQ); quality of life: Medical Outcomes Short Form-36 (SF-36) and depression: Beck’s Depression Inventory-II (BDI-II). At the baseline, patients in IG were assessed by a physician (medical history, mRSS, ESSG activity score, MITAX, MYOACT) and by a physiotherapist (pelvic floor function assessment–PERFECT scheme, MMT-8, Functional Index-II). Normality of data was tested, and inter-group analysis was performed with 2-way ANOVA and intra-group analysis by Friedmann’s test.

Results: Compared to observed statistically significant deterioration in CG over the period of weeks 0-8, we found statistically significant improvement in both sexual function questionnaires: FSFI (p=0.043), BISF-W (p=0.040), functional status: HAQ (p=0.018), and quality of life: SF-36 Physical Somponent score (0.050). Only numerical improvement in IG compared to numerical deterioration in CG, which has not reached statistical significance, was observed in SQoL-F, BDI-II, and SF-36 Mental Component Score.

Conclusion:
Our physiotherapy program not only prevented the natural course of progressive deterioration of functional abilities, but also led to a significant improvement in sexual function and overall quality of life in women with SSc and IIM. Physical therapy might become one of the possible therapeutic treatments for sexual problems in women with SSc and IIM. This pilot study should be validated on larger cohorts, optimally in a randomized manner, which was not applicable in our case, due to the limited number of volunteers who met the criteria.

Supporting image 1

Significant and non-significant changes wchich we observed after 8 week of physical therapy program in the intervention group compared to the control group


Disclosures: B. Hermankova, None; M. Spiritovic, None; S. Oreska, None; H. Storkanova, None; K. Pavelka, MSD, Pfizer, Roche, Eli Lilly, Medac, UCB, SOBI, Biogen, Sandoz, Viatris; L. Šenolt, None; J. Vencovský, Abbvie, Biogen, Boehringer, Eli Lilly, Gilead, Kezar, Merck, Novartis, Octapharma, Pfizer, Takeda, UCB, Werfen, Argenx; R. Becvar, None; M. Tomcik, None.

To cite this abstract in AMA style:

Hermankova B, Spiritovic M, Oreska S, Storkanova H, Pavelka K, Šenolt L, Vencovský J, Becvar R, Tomcik M. Effect of an 8-week Tailored Physical Therapy Program on Sexual Function in Women with Systemic Sclerosis and Idiopathic Inflammatory Myopathies: A Pilot Controlled Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/effect-of-an-8-week-tailored-physical-therapy-program-on-sexual-function-in-women-with-systemic-sclerosis-and-idiopathic-inflammatory-myopathies-a-pilot-controlled-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-an-8-week-tailored-physical-therapy-program-on-sexual-function-in-women-with-systemic-sclerosis-and-idiopathic-inflammatory-myopathies-a-pilot-controlled-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology